Amerisource Health Services LLC is recalling 3,344 cartons of American Health Packaging Hydralazine Hydrochloride (hydralazine hydrochloride) 10 mg tablets, a medication used to treat high blood pressure. The recall was issued because the tablets failed impurity and degradation specifications during a 12-month testing point. No incidents or injuries have been reported to date.
The product exceeded specification limits for impurities, which may affect the medication's quality and long-term stability. While no injuries are reported, consuming medication with excessive degradation products could potentially lead to health risks.
You have 2 options:
Recall #: D-0039-2024
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.